The Next Wave of Science: Will FDA Approve Cell Therapy?

The video discusses recent advancements in cancer treatments, highlighting their potential to send patients into remission but also their associated risks, such as neurotoxicity and inflammatory responses. It explores the commercial future of these treatments, noting their high costs due to individualized production. The video also addresses the broader implications for drug pricing debates, emphasizing the need for innovation despite potential controversies over pricing.

What implications do the recent patient deaths have on the future of these treatments?

In what ways do the new treatments differ from traditional cancer therapies?